品牌簡介

NeuroMab Facility is a purely academic monoclonal antibody (mAb) facility as funded by NIH awards U24 NS050606 (2005-2014), R24 NS092991 (2015-2019), and U24 NS109113 (2019-present). Our mission is to provide a unique neuroscience-based approach to generating mouse mAbs optimized for use in mammalian brain (NeuroMabs), and to convert them into recombinant form.